Log In
BCIQ
Print this Print this
 

JCAR014

  Manage Alerts
Collapse Summary General Information
Company Juno Therapeutics Inc.
DescriptionAutologous T cells expressing a chimeric antigen receptor (CAR) specific to the CD19 antigen
Molecular Target CD19
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$150.2M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/29/2015

Undisclosed

$150.2M

0

Get a free BioCentury trial today